02/24/2020
The firm highlights that its first and foremost priority is generating sustainable alpha for its clients, and as such APS feels that its resources require a strong focus on China, where its clients’ exposure is.
02/21/2020
AXA Affin Life, set up in 2006, is 51% owned by Affin and 49% owned by Axa.
02/21/2020
Deal will expand the business’ international presence
02/20/2020
Buyers expect overlap in UK, European and Asian equities.
02/20/2020
As an advanced VHIS flexi plan that adds to the two VHIS plans launched by Manulife last year, Manulife Supreme is designed to gives customers prompt access to high-quality medical care whenever they need it.
02/20/2020
Urusharta Jamaah will buy non-performing assets from the fund at the original value to ensure the continuity of the fund’s operations.
02/20/2020
Ride-hailing unicorn will offer development skills and data for 'super app'
02/20/2020
OneVue's receivers PwC have appointed Bob Neill of Seaview Consulting Pty to look for potential buyers for Madison.
02/19/2020
Korean asset owners are allocating more of their portfolio to riskier assets, either through domestic equity, global fixed income and alternative investment
02/19/2020
Globally, deals are expected to be maintained at the recent trend level at just under 200 in the first half of 2020
02/19/2020
The US firm had a joint venture with Ping An, which ended in 2015.
02/19/2020
The new ETF currently is reported to have over USD120 million AUM, including a start-up contribution from UBS.
02/19/2020
As of February 14th 2020, Premia Partners has 6 ETFs listed on HKEX covering China, Emerging ASEAN, Asia Innovative Technology, Vietnam and US Treasury exposures, and has celebrated its third anniversary.
02/19/2020
The insurance is a fully digital offering and can be bought in a matter of minutes, according to the two companies.
02/19/2020
It has about 310 clients across Australia and a Melbourne-based team of 35, which includes two authorised representatives of Synchron.
02/19/2020
The wins are based on Rainmaker analysis of more than seven factors, including performance across multiple time periods, volatility, downside risk, and multiple performance ratios such as Sharpe and Sortino.
02/19/2020
Mediq will expand our Australian presence and add a specialist partner whose unique value proposition will enable it to capitalize on opportunities in an attractive and growing market
02/18/2020
Mercer will recommend the underlying funds of the portfolio.
02/18/2020
GIC’s other commercial property deals in China since 2018 include a joint venture with Singapore real estate firm CapitaLand to acquire Shanghai's tallest twin towers for 12.8 billion RMB.
02/18/2020
The fund is managed by CICC Capital’s Xiamen-based biomedical unit and will invest in China’s biological medicine industry.